Clinical trial

A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

NCT03866499

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention BPI-7711 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gefitinib Normalized identity: gefitinibView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Tablet Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo capsule Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-04-30

PhasePHASE3

Conditions

NSCLCverified · MONDO: non-small cell lung carcinoma

Interventions

BPI-7711DRUG

GefitinibDRUG · verified · RxNorm: gefitinib

Placebo TabletDRUG

Placebo capsuleDRUG

Sponsors & collaborators

Beta Pharma Shanghailead sponsor

Mapped research locations

BeijingBeijing Municipality, China1 ZhengzhouHenan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03866499 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.